Morgan Stanley raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $70 and keeps an Equal Weight rating on the shares.
In a report released today, Brandt Montour from Barclays maintained a Hold rating on Marriott International (MAR – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback